AI Medical Technology

AI Medical Technology offers Dermalyser, an AI-powered app for safer and faster skin cancer diagnosis. It provides 96% accuracy in assessing skin lesions, supporting medical professionals with instant decision support.

Claim this tool

No Views Yet

At a glance

Pricing

Likely Not Free

Free tier

API

Skill level

Technical

About

What is AI Medical Technology?

AI Medical Technology develops AI-powered diagnostic solutions for healthcare professionals. Their flagship product, Dermalyser, is a CE-marked app that provides AI-driven decision support for assessing suspected skin melanomas. By analyzing dermatoscopic images captured with a smartphone, Dermalyser offers immediate feedback with 96% accuracy (AUC), 95% sensitivity, and 85% specificity in melanoma detection. This tool is designed to optimize clinical workflow, reduce unnecessary referrals and procedures, and provide peace of mind for doctors. It is validated in prospective clinical studies and intended for licensed healthcare professionals like dermatologists and primary care physicians, acting as an assistant rather than a replacement for clinical judgment.

Best used for

Ideal for primary care physicians and dermatologists who need to quickly and accurately assess suspected skin melanomas, reduce unnecessary referrals, and enhance diagnostic confidence. Especially valuable for integrating AI decision support into existing clinical workflows using a smartphone and dermatoscope.

Common actions

diagnose skin cancer

assess skin lesions

optimize clinical workflow

reduce referrals

Capabilities

Key features

AI-powered lesion analysis
96% accuracy (AUC)
CE-marked medical device
Smartphone image capture
Optimized clinical workflow
Reduced unnecessary referrals

Target Audience

doctordermatologist

Integrations

Not yet documented

Pricing & Plans

Likely Not Free

Not publicly disclosed. Check aimedtech.com for current pricing.

FAQs

What is Dermalyser and how does it work?

Dermalyser is a CE-marked software that uses artificial intelligence to analyze digital dermatoscopic images of skin lesions captured with a smartphone. It functions as a decision-support tool for healthcare professionals when assessing suspected skin melanomas, providing immediate feedback on the likelihood of malignancy.

Who is allowed to use Dermalyser?

Only licensed healthcare professionals, such as general practitioners, primary care physicians, and dermatologists, are permitted to use Dermalyser. It is designed to support their clinical judgment and not to replace it, with the final diagnosis always made by the healthcare professional.

What are the limitations for using Dermalyser?

Dermalyser should not be used on patients under 18, ulcerated/open lesions, lesions smaller than 2mm or larger than 2cm, on mucous membranes, under nails, on palms/soles, near eyes, on tattooed skin, or on previously biopsied lesions. It is intended only for suspected melanomas.

Is Dermalyser a certified medical device?

Yes, Dermalyser is CE-marked under MDR (EU) 2017/745 as a Class IIa medical device software. It is also continuously monitored in clinical practice to ensure safety and performance in line with regulatory requirements.

Trending

Subcategories trending in Wellness & Lifestyle

Health & Fitness Gaming & Entertainment Mental Wellness Self-Improvement Medical & Symptom Checking Home & Real Estate

Trending

Explore

Browse AI tools by category

Content & Design Productivity & Business Coding & Development AI Agents & Automation Research & Education Wellness & Lifestyle Career Development Marketing & Growth Data & Analytics Customer Support & CX Finance E-commerce